1,200 articles
Jeffrey A. Bluestone
Jeffrey A. Bluestone is an American immunologist and UCSF professor whose research on T-cell tolerance produced CTLA4Ig and teplizumab, the first drug approved to delay type 1 diabetes.
Jeffrey A. Engelman
Jeffrey A. Engelman is an American oncologist who studied resistance to targeted kinase inhibitors in lung cancer at Mass General, then joined Novartis in 2016 and co-founded Treeline Biosciences.
Jeffrey A. Meyerhardt
Jeffrey A. Meyerhardt is an American gastrointestinal medical oncologist at Dana-Farber Cancer Institute in Boston, where he leads colorectal cancer research and national phase 3 clinical trials.
Jeffrey R. Smith
Jeffrey R. Smith is an American physician-scientist and Associate Professor of genetic medicine at Vanderbilt University, known for hereditary prostate cancer genetics research and the 2001 PECASE award.
Jeffrey S. Weber
Jeffrey S. Weber, also known as Jeffrey Weber, was an American medical oncologist and melanoma immunotherapy researcher who served as Deputy Director of NYU Langone's Perlmutter Cancer Center.
Jeffrey Schlom
Jeffrey Schlom is an American cancer immunologist who led the National Cancer Institute's Laboratory of Tumor Immunology and Biology for about 30 years and developed the PANVAC and PROSTVAC vaccines.
Jeffrey Settleman
Jeffrey Settleman is an American cancer biologist who serves as Chief Scientific Officer for Oncology R&D at Pfizer, after 18 years as a Harvard Medical School professor.
Jeffrey Struewing
Jeffrey P. Struewing is an American physician-scientist in cancer genetics whose 1997 NEJM study re-estimated BRCA1 and BRCA2 cancer risks in Ashkenazi Jews, earning a 1998 PECASE.
Jeffrey Tyner
Jeffrey Tyner is an American hematology and oncology researcher at Oregon Health & Science University in Portland, known for the Beat AML drug-profiling program in acute myeloid leukemia.
Jeffrey W. Smith
Jeffrey W. Smith is an American cell biologist known for integrin ligand binding research and for discovering that orlistat inhibits fatty acid synthase and slows tumor growth.
Jennifer A. Woyach
Jennifer A. Woyach is an American hematologist-oncologist and professor at Ohio State University whose chronic lymphocytic leukemia research identified ibrutinib resistance mechanisms and led major frontline clinical trials.
Jennifer R. Grandis
Jennifer R. Grandis is an American otolaryngologist and head and neck cancer researcher at UCSF, known for her work on EGFR and STAT3 signaling in head and neck squamous cell carcinoma.
Jennifer S. Temel
Jennifer S. Temel is an American oncologist at Massachusetts General Hospital known for her 2010 trial showing early palliative care improved survival in lung cancer.
Jennifer Wargo
Jennifer A. Wargo is an American surgeon and cancer immunotherapy researcher at MD Anderson Cancer Center, known for showing that the gut microbiome influences immunotherapy response.
Jens Overgaard
Jens Overgaard is a Danish physician-scientist and professor of experimental clinical oncology at Aarhus University Hospital, known for the DAHANCA fractionation trials in head-and-neck cancer.
Jeremy N. Rich
Jeremy N. Rich is an American neuro-oncologist and cancer stem cell researcher known for his work on glioblastoma stem cells. In 2025 he became deputy director for research and chief scientific officer of UNC Lineberger.
Jerome B. Posner
Jerome B. Posner, born 1932, is an American neurologist who built neuro-oncology at Memorial Sloan Kettering, defined paraneoplastic syndromes, and co-wrote Diagnosis of Stupor and Coma.
Jérôme Galon
Jérôme Galon is a French cancer immunologist, Research Director at Inserm in Paris, who originated the immune contexture concept and the Immunoscore assay for cancer prognosis.
Jerri Nielsen
Jerri Nielsen FitzGerald (1952-2009), American ER physician who self-diagnosed and treated her breast cancer as sole doctor at Amundsen-Scott South Pole Station in winter 1999, aided by a midwinter airdrop and October Air National Guard rescue; author of Ice Bound.
Jesper Lagergren
Jesper Lagergren is a Swedish academic surgeon and epidemiologist who studies esophageal and gastric cancer, holding professorships at Karolinska Institutet and King's College London and a 1999 NEJM study linking reflux to esophageal adenocarcinoma.
Jewel Plummer Cobb
Jewel Plummer Cobb (1924–2017) was an American cell biologist known for melanoma and pigment-cell research, and president of California State University, Fullerton from 1981 to 1990.
Jianjun Chen
Jianjun Chen is a Chinese-born American cancer biologist who is Professor and Chair of Systems Biology at City of Hope in Duarte, California, known for RNA methylation research in leukemia.
Jie He
Jie He (赫捷) is a Chinese thoracic surgeon and oncologist who directs the National Cancer Center of China and was elected to the US National Academy of Medicine in 2025.
Jinghui Zhang
Jinghui Zhang is a cancer genomics researcher at St. Jude Children's Research Hospital in Memphis who maps pediatric cancer genomes and built tools including ProteinPaint and St. Jude Cloud.
Jinming Gao
Jinming Gao is a chemist and biomedical engineer, professor at UT Southwestern Medical Center, known for pH-responsive proton transistor nanoparticles, the PC7A STING nanovaccine, and founding OncoNano Medicine.
Joan Massagué
Joan Massagué is a Spanish-born cancer biologist known for defining the TGF-β signaling pathway and the molecular basis of cancer metastasis, and director of the Sloan Kettering Institute since 2014.
Joanna Wysocka
Joanna Wysocka is a Polish-born American developmental biologist and HHMI investigator at Stanford who studies how chromatin regulates gene expression during development, evolution, and disease.
Joffre Baker
Joffre Baker is a biochemist and cancer researcher known for discovering protease-nexin, a cell-surface protease regulator, and for the Oncotype DX 21-gene breast cancer test developed at Genomic Health.
Johann S. de Bono
Johann S. de Bono, also known as Johann de Bono, is a British medical oncologist and Regius Professor of Cancer Research who led pivotal trials of abiraterone, enzalutamide, and olaparib.
Johanna Joyce
Johanna A. Joyce is a cancer biologist and Full Professor of Oncology at the University of Lausanne, known for reprogramming tumor-associated macrophages to slow glioblastoma.